NSE filing, NSE: PROLIFE. Summary written from the filing by ALFA Finder's alert engine.
Prolife Industries Ltd: key numbers
- Share price
- ₹79.80
- Market cap
- ₹32.67 Cr
- Revenue (annual)
- ₹54.52 Cr
- Net profit (annual)
- ₹4.25 Cr
- P/E (TTM)
- 7.7×Sector 34.5×
- Promoter holding
- 73.74%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prolife Industries Ltd
All →Prolife Industries Annual General Meeting
Prolife Industries Limited held its 32nd Annual General Meeting on September 25, 2026. Shareholders approved financial statements, a dividend, director reappointments, and related party transactions.
Prolife Industries Annual General Meeting
Prolife Industries Limited announced the book closure and record date for its upcoming 32nd Annual General Meeting and dividend. Book closure spans September 19-25, 2026.
Prolife Industries Other Announcement
Prolife Industries Limited notified shareholders about the dispatch of Annual Report weblinks for the 32nd AGM as per Regulation 36(1)(b) compliance.
Prolife Industries Annual General Meeting
Prolife Industries Limited has scheduled its 32nd Annual General Meeting for September 25, 2026. The Annual Report for 2025-26 is available on the company's website.
Prolife Industries Dividend
Prolife Industries recommended a final dividend of Rs. 0.30 per equity share for FY 2025-26. The 32nd Annual General Meeting is scheduled for September 25, 2026.
Prolife Industries Board Meeting Date
Prolife Industries Limited has scheduled a board meeting for August 26, 2026, to discuss dividend declaration and other business matters.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.